Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: KINIKSA PHARMACEUTICALS (UK), LTD.
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2022-03-02 to 2023-01-12
Current total value of award: $42000
Description: ARCALYST (RILONACEPT) 220MG/VIAL INJECTION